Table 1.
Baseline patient and tumor characteristics: Patient information including starting CP score, age, tumor size, etiology of liver disease, and therapies before SBRT
| Baseline patient and tumor characteristics | All patients | CP 7 | CP 8 | CP 9 | CP 10 | |
|---|---|---|---|---|---|---|
| No patients | 23 | 3 | 6 | 9 | 5 | |
| Median age (range) | 62 (41-82) | 62 | 61.5 | 56 | 65 | |
| Median tumor size (range) | 3.1 cm (1-10) | 4 cm | 2.7 cm | 2.6 cm | 3.2 cm | |
| Etiology of liver disease | ||||||
| EtOH | 8 | 1 | 1 | 3 | 3 | |
| HCV | 3 | 1 | 1 | 1 | 0 | |
| HBV | 1 | 0 | 0 | 1 | 0 | |
| NASH | 2 | 1 | 1 | 0 | 0 | |
| PBC | 1 | 0 | 1 | 0 | 0 | |
| EtOH + HCV | 8 | 0 | 2 | 4 | 2 | |
| All patients |
Median interval |
|||||
| Total no. previous TACE | 18 | 3 | 5 | 5 | 5 | 75.5 days |
| Salvage | 10 | 1 | 3 | 4 | 2 | 178 days |
| CMT | 8 | 2 | 2 | 1 | 3 | 46 days |
Abbreviations: CMT = combined modality treatment; CP = Child-Pugh; EtOH = ethanol; HBV = hepatitis B; HCV = hepatitis C; NASH = nonalcoholic steatohepatitis; PBC = primary biliary cirrhosis; SBRT = stereotactic body radiation therapy; TACE = transarterial chemoembolization.